FDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial

dart board with a red dart in the center bulls eye

Inova’s Dr. John Deeken served as the site principal investigator for this prestigious study In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or Vitrakvi®, that targets specific genetic mutations in adult and pediatric patients. This is only the second tissue-agnostic…

Read More

Men and BRCA Testing: What You Need To Know

Sarah Ruppert, MS, CGC, is a certified genetic counselor and genetics program supervisor at the Inova Translational Medicine Institute. Read Sarah Ruppert’s profile. If you’re familiar with the BRCA1 and BRCA2 genes, odds are good you think of them as “breast cancer genes.” Indeed, mutations in these two genes are associated with a significantly increased…

Read More

Genetic Counselors In Growing Demand as Genetic Testing Takes Off

Benjamin D. Solomon leads the Medical Genomics Division at the Inova Translational Medicine Institute. He performs genome-based research to find the causes of patients’ genetic disorders and is also involved in the clinical care of patients with genetic conditions. He is board certified in clinical genetics and pediatrics. Read Dr. Solomon’s profile. Last year, a…

Read More

Children’s National and Inova Collaborate in Pediatric Specialty Care

Fairfax, Va (September 30, 2013) — Pediatric Specialists of Virginia begins operations today as a collaboration between Children’s National and Inova. Designed to make pediatric specialty care more accessible to families in Virginia, the specialty practice offers pediatric services in:  Oncology and Hematology, Gastroenterology, Genetics, Nephrology, and Orthopaedics. Additional services will be added in the…

Read More